Predictive Oncology Inc (POAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,624 | 1,628 | 1,506 | 1,421 | 1,252 |
| Cost of Goods | 826 | 609 | 505 | 487 | 447 |
| Gross Profit | 798 | 1,019 | 1,000 | 934 | 805 |
| Operating Expenses | 12,563 | 13,745 | 27,539 | 21,849 | 26,612 |
| Operating Income | -10,940 | -12,118 | -26,034 | -20,429 | -25,360 |
| Other Income | 79 | 100 | 296 | 110 | -524 |
| Pre-tax Income | -10,860 | -12,018 | -25,738 | -20,319 | -25,884 |
| Income Tax | N/A | N/A | N/A | -662 | N/A |
| Net Income Continuous | -10,860 | -12,018 | -25,738 | -19,657 | -25,884 |
| Net Income Discontinuous | -1,804 | -1,966 | N/A | N/A | N/A |
| Net Income | $-12,664 | $-13,984 | $-25,738 | $-19,657 | $-25,884 |
| EPS Basic Total Ops | -34.78 | -52.17 | -104.65 | -107.95 | -662.67 |
| EPS Basic Continuous Ops | -29.84 | -44.83 | -104.69 | -107.41 | -649.49 |
| EPS Basic Discontinuous Ops | -4.95 | -7.35 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -34.78 | -52.17 | -104.65 | -107.95 | -662.67 |
| EPS Diluted Continuous Ops | -29.84 | -44.83 | -104.69 | -107.41 | -649.49 |
| EPS Diluted Discontinuous Ops | -4.95 | -7.35 | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -29.84 | -52.17 | -74.96 | -68.97 | -428.79 |
| EBITDA(a) | $-10,244 | $-11,393 | $-21,371 | $-15,950 | $-23,089 |